Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1-Reference-Cited by-同舟云学术

Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1

Published:2019 Issue:3 Volume:97 Page:135-148
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Ito Zensho,Kan Shin,Bito Tsuuse,Horiuchi Sankichi,Akasu Takafumi,Yoshida Sayumi,Kajihara Mikio,Hokari Atsushi,Saruta Masayuki,Yoshida Noriyuki,Kobayashi Masanori,Ohkusa Toshifumi,Shimodaira Shigetaka,Okamoto Masato,Sugiyama Haruo,Koido Shigeo

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference39 articles.

1. Spadi R, Brusa F, Ponzetti A, Chiappino I, Birocco N, Ciuffreda L, et al. Current therapeutic strategies for advanced pancreatic cancer: a review for clinicians. World J Clin Oncol. 2016 Feb;7(1):27–43.

2. Koido S, Okamoto M, Shimodaira S, Sugiyama H. Wilms’ tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer. Immunotherapy. 2016 Nov;8(11):1309–20.

3. Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, et al. The prioritization of cancer antigens: a National Cancer Institute pilot project for the acceleration of translational research. Clin Cancer Res. 2009 Sep;15(17):5323–37.

4. Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T, et al. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol. 2006 Jun;19(6):804–14.

5. Oji Y, Nakamori S, Fujikawa M, Nakatsuka S, Yokota A, Tatsumi N, et al. Overexpression of the Wilms’ tumor gene WT1 in pancreatic ductal adenocarcinoma. Cancer Sci. 2004 Jul;95(7):583–7.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wilms Tumor: Updates about Pathogenesis and New Possible Clinical Treatments of the Most Frequent Pediatric Urogenital Cancer: A Narrative Review;Surgeries;2023-12-08

2. Gene knockout in cellular immunotherapy: Application and limitations;Cancer Letters;2022-08

3. Targeting TGF-β signal transduction for fibrosis and cancer therapy;Molecular Cancer;2022-04-23

4. MicroRNA ‐216a targets WT1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer—A transcriptome analysis;IUBMB Life;2021-04-03

5. Do novel treatment strategies enhance T cell-mediated Immunity: Opportunities and challenges in pancreatic cancer immunotherapy;International Immunopharmacology;2021-01